Filing Details
- Accession Number:
- 0001385508-22-000112
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-15 16:06:56
- Reporting Period:
- 2022-07-14
- Accepted Time:
- 2022-07-15 16:06:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1385508 | Opiant Pharmaceuticals Inc. | OPNT | Pharmaceutical Preparations (2834) | 464744124 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1491140 | D David O'toole | C/O Opiant Pharmaceuticals, Inc. 233 Wilshire Boulevard, Suite 400 Santa Monica CA 90401 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-07-14 | 779 | $11.10 | 36,804 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold to cover tax withholding obligations in connection with the vesting of performance stock units.
- This transaction was executed in multiple trades at prices ranging from $10.82 to $11.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
